Company

Company Profile

Intuitive Surgical, Inc. (NASDAQ: ISRG) is the global technology leader in robotic-assisted minimally invasive surgery (MIS). The Company's da Vinci® Surgical System offers surgeons superior 3D HD visualization, enhanced dexterity, greater precision and ergonomic comfort for the optimal performance of MIS. The da Vinci System enables surgeons to perform even complex procedures such as heart valve and cancer surgery through 1-2 cm incisions.

This breakthrough is allowing hospitals everywhere to extend the benefits of MIS to a broader base of patients. An investment in an MIS initiative built around the da Vinci Surgical System can provide hospitals with greater productivity and operational efficiencies. Improved operational efficiencies may result in reduced incidence of complications and post-operative infections; reduced need for blood transfusions and post-operative pain management, simplified post-operative nursing care and reduced length of stay.

The original prototype for Intuitive Surgical’s da Vinci System was developed in the late 1980s at the former Stanford Research Institute under contract to the U.S. Army. While initial work was funded in the interest of developing a system for performing battlefield surgery remotely, possible commercial applications were even more compelling: It was clear to those involved that this technology could accelerate the application of a minimally invasive surgical approach to a broader range of procedures.

In 1995, Intuitive Surgical was founded to test this theory. In January 1999, Intuitive launched the da Vinci Surgical System, and in 2000, it became the first robotic surgical system cleared by the FDA for general laparoscopic surgery. In the following years, the FDA cleared the da Vinci Surgical System for thoracoscopic (chest) surgery, cardiac procedures performed with adjunctive incisions, urologic, gynecologic, pediatric and transoral otolaryngology procedures. In June 2000, Intuitive Surgical completed a successful initial public offering. This was followed by a second successful public offering in 2003. In 2003, the company also acquired its principal competitor, Computer Motion, strengthening its intellectual property holdings.

Today, more than 1,840 da Vinci Systems are installed in over 1,450 hospitals worldwide. As of March 31, 2011, Intuitive Surgical held exclusive field-of-use license for more than 870 U.S. and foreign patents as well as more than 990 pending U.S. and foreign patent applications. Intuitive Surgical’s patents and patent applications relate to a number of important aspects of its technology, including the surgeon console, electromechanical arms, vision system, endoscope positioning system and EndoWrist instruments. In addition to developing its own proprietary technologies, Intuitive Surgical has established relationships with several industry leaders including IBM Corporation, Massachusetts Institute of Technology (MIT), Johns Hopkins University (JHU) and Heartport, Inc. (Johnson & Johnson). The Company has also entered into industry collaborations with companies including Ethicon Endo-Surgery (Johnson & Johnson), Luna Innovations, Power Medical Interventions, Teleflex Medical, InTouch Health, Stryker, Novadaq and Mimic.

Headquartered in Sunnyvale, California, Intuitive Surgical has more than 1,729 employees in offices worldwide. Intuitive Surgical ended the first quarter of 2011 with cash, cash equivalents and investments of $1.8 billion, up $388 million from March 31, 2010. First quarter 2011 operating income increased to $148 million, compared with $130 million for the first quarter of 2010.

The da Vinci System is the #1 option for minimally invasive hysterectomy in the United States,1 the #1 surgical treatment option for U.S. women diagnosed with gynecologic cancer,1 and is chosen by more U.S. men than any other treatment for prostate cancer.2

PN 871072 Rev I 06/11

While clinical studies support the effectiveness of the da Vinci Surgical System when used in minimally invasive surgery, individual results may vary. There are no guarantees of outcome. All surgeries involve the risk of major complications. Before you decide on surgery, discuss treatment options with your doctor. Understanding the risks of each treatment can help you make the best decision for your individual situation. Surgery with the da Vinci Surgical System may not be appropriate for every individual; it may not be applicable to your condition. Always ask your doctor about all treatment options, as well as their risks and benefits. Only your doctor can determine whether da Vinci Surgery is appropriate for your situation. The clinical information and opinions, including any inaccuracies expressed in this material by patients or doctor about da Vinci Surgery are not necessarily those of Intuitive Surgical, Inc. and should not be considered as substitute for medical advice provided by your doctor. All persons depicted are models unless otherwise noted. © 2012 Intuitive Surgical. All rights reserved. Intuitive, Intuitive Surgical, da Vinci, da Vinci S, da Vinci Si, Single-Site,  InSite, TilePro and EndoWrist are trademarks or registered trademarks of Intuitive Surgical. All other product names are trademarks or registered trademarks of their respective holders.


1Claim based on 2011 U.S. data. Data on file at Intuitive Surgical, Inc.
2Claim based on Thompson Healthcare’s Solucient Database (US, 2008) from reporting hospitals in Thompson Healthcare's dataset, on file at Intuitive Surgical, Inc.






 



About the da Vinci System